References
- GastautHRogerJSoulayrolRChildhood epileptic encephalopathy with diffuse slow spike-waves (otherwise known as “petit mal variant”) or Lennox-Gastaut syndromeEpilepsia1966721391794959714
- WhelessJWConstantinouJECLennox-Gastaut syndromePediatr Neurol19971732032119390695
- MarkandONLennox-Gastaut syndrome (childhood epileptic encephalopathy)J Clin Neurophysiol200320642644114734932
- ArzimanoglouAFrenchJBlumeWTLennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodologyLancet Neurol20098829319081517
- FerrieCDPatelATreatment of Lennox-Gastaut syndromeEur J Paediatr Neurol2009In press, doi:10.1016/j.ejpn.2008.12.005.
- OguniHHayashiKOsawaMLong-term prognosis of Lennox-Gastaut syndromeEpilepsia199637Suppl 344478681912
- HancockECCrossHHJTreatment of Lennox-Gastaut syndromeCochrane database Syst Rev20033CD00327712917958
- RitterFJLeppikIEDreifussFEFelbamate Study GroupEfficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome)N Engl J Med1993328129338347179
- MotteJTrevathanEArvidssonJFLamictal Lennox-Gastaut Study GroupLamotrigine for generalized seizures associated with the Lennox-Gastaut syndromeN Engl J Med199733725180718129400037
- SachdeoRCGlauserTARitterFA double-blind, randomized trial of topiramate in Lennox-Gastaut syndromeNeurology19995291882188710371538
- SchmidtDBourgeoisBA risk-benefit assessment of therapies for Lennox-Gastaut syndromeDrug Saf200022646747710877040
- WhelessJWClarkeDFCarpenterDTreatment of pediatric epilepsy: expert opinionJ Child Neurol200520Suppl 1S1S6016615562
- ConryJANgYTPaolicchiJMClobazam in the treatment of Lennox-Gastaut syndromeEpilepsia20095051158116619170737
- CortezMAMcKerlieCSneadOC3rdA model of atypical absence seizures: EEG, pharmacology, and developmental characterizationNeurology200156334134911171899
- HornCSAterSBHurstDLCarbamazepine-exacerbated epilepsy in children and adolescentsPediatr Neurol1986263403453508708
- BrodieMJRosenfeldWEVazquezBRufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trialEpilepsia2009In press, doi:10.1111/j.1528-1167.2009.02160.x.
- McLeanMJSchmutzMPozzaMWamilAThe influence of rufinamide on sodium currents and action potential firing in rodent neurons [abstract 3.061]Epilepsia200546Suppl 8296
- RogawskiMADiverse mechanisms of antiepileptic drugs in the development pipelineEpilepsy Res20066927329416621450
- WhiteHSFranklinMRKupferbergHJSchmutzMStablesJPWolfHHThe anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure modelsEpilepsia20084971213122018325020
- ArroyoSRufinamideNeurotherapeutics20074115516217199032
- AldenkampAPAlphertsWCJThe effect of the new antiepileptic drug rufinamide on cognitive functionsEpilepsia20064771153115916886978
- PeruccaEJCloydJCritchleyDFuseauERufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsyEpilepsia20084971123114118503564
- DeeksEDScottLJRufinamideCNS Drugs200620975176016953653
- GlauserTKlugerGSachdeoRKraussGPerdomoCArroyoSRufinamide for generalized seizures associated with Lennox-Gastaut syndromeNeurology200870211950195818401024
- GlauserTKlugerGSachdeoRKraussGPerdomoCArroyoSOpen-label extension study of the efficacy and safety of rufinamide adjunctive therapy in patients with Lennox-Gastaut syndrome [abstract 1356]Epilepsia200546Suppl 6408
- KlugerGKurlemannGHaberlandtEEffectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experienceEpilepsy Behav200914349149519162229